News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 7, 2021

Educated Patient® Breast Cancer Summit: March 7, 2021

Author(s)CURE staff

View the full CURE Educated Patient Breast Cancer Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER+/HER2– breast cancer: © stock.adobe.com.

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

ByCourtney Flaherty

December 26th 2025

Image of ribbons.

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer

December 25th 2025

Learn how diet and exercise significantly impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs: © stock.adobe.com.

How Nutrition Impacts Breast Cancer Risk and Recovery

December 25th 2025

Debbie Legault is the mother of a young woman who was diagnosed with breast cancer at 27. Catch up on Debbie’s blogs here!

One More Christmas: How Cancer Changed How I Experience the Holidays

ByDebbie Legault

December 24th 2025

Trodelvy elicited fewer side effects vs chemo in previously untreated TNBC: © stock.adobe.com.

Trodelvy Shows Fewer Side Effects Than Chemotherapy in Some With TNBC

December 24th 2025

Trending on CURE

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

Advice for Patients Newly Diagnosed With Multiple Myeloma

A Five-Time Cancer Survivor’s Advice for Patients

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer